FI974346A0 - Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi - Google Patents

Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi

Info

Publication number
FI974346A0
FI974346A0 FI974346A FI974346A FI974346A0 FI 974346 A0 FI974346 A0 FI 974346A0 FI 974346 A FI974346 A FI 974346A FI 974346 A FI974346 A FI 974346A FI 974346 A0 FI974346 A0 FI 974346A0
Authority
FI
Finland
Prior art keywords
prevention
tissue necrosis
respiratory disorder
adult patient
reperfusion damage
Prior art date
Application number
FI974346A
Other languages
English (en)
Swedish (sv)
Other versions
FI974346A (fi
Inventor
Barbara A Araneo
Imad S Farrukh
Raymond A Daynes
Urszula Orlinska
Original Assignee
Paradigm Biosciences Inc
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/480,744 external-priority patent/US5587369A/en
Priority claimed from US08/480,748 external-priority patent/US5686438A/en
Priority claimed from US08/480,745 external-priority patent/US5635496A/en
Application filed by Paradigm Biosciences Inc, Univ Utah Res Found filed Critical Paradigm Biosciences Inc
Publication of FI974346A0 publication Critical patent/FI974346A0/fi
Publication of FI974346A publication Critical patent/FI974346A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI974346A 1995-06-07 1997-11-26 Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi FI974346A (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/480,744 US5587369A (en) 1993-03-09 1995-06-07 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US08/480,748 US5686438A (en) 1993-03-09 1995-06-07 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US08/480,745 US5635496A (en) 1993-03-09 1995-06-07 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US08/516,540 US5846963A (en) 1995-06-07 1995-08-18 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
PCT/US1995/010990 WO1996040152A1 (en) 1995-06-07 1995-09-08 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome

Publications (2)

Publication Number Publication Date
FI974346A0 true FI974346A0 (fi) 1997-11-26
FI974346A FI974346A (fi) 1998-01-16

Family

ID=27504245

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974346A FI974346A (fi) 1995-06-07 1997-11-26 Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi

Country Status (8)

Country Link
US (1) US5846963A (fi)
EP (1) EP0835113A1 (fi)
JP (1) JPH11124393A (fi)
AU (1) AU699749B2 (fi)
CA (1) CA2223739A1 (fi)
FI (1) FI974346A (fi)
NO (1) NO975717L (fi)
WO (1) WO1996040152A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977095A (en) * 1993-03-09 1999-11-02 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
ID24720A (id) * 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
WO2001023405A2 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
EP2298316A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
US20040121991A1 (en) * 2002-12-20 2004-06-24 Araneo Barbara A. Dehydroepiandrosterone (DHEA) congeners for prevention and/or treatment of ulcers
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JP2010511611A (ja) * 2006-12-01 2010-04-15 シマ ラブス インク． 口腔経粘膜ニコチン剤形
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
WO2010107922A1 (en) * 2009-03-17 2010-09-23 Duke University Neuroactive steroid compositions and methods of use for lowering cholesterol
BR112012008352A2 (pt) * 2009-09-11 2016-03-22 Bionature E A Ltd uso de compostos esteroides para distúrbios inflamatório e autoimune

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5110810A (en) * 1991-02-08 1992-05-05 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation
US5162198A (en) * 1991-02-08 1992-11-10 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation
HUT72968A (en) * 1993-03-09 1996-06-28 Univ Utah Res Found Process for producing pharmaceutical composition which is applicable for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome

Also Published As

Publication number Publication date
AU699749B2 (en) 1998-12-10
US5846963A (en) 1998-12-08
AU3541395A (en) 1996-12-30
WO1996040152A1 (en) 1996-12-19
EP0835113A1 (en) 1998-04-15
JPH11124393A (ja) 1999-05-11
FI974346A (fi) 1998-01-16
NO975717L (no) 1998-02-04
NO975717D0 (no) 1997-12-05
CA2223739A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
FI974346A0 (fi) Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi
AU5343899A (en) Catheter drug delivery system and method for use
EP1011607A4 (en) METHODS FOR PREVENTING PROGRESSIVE TISSUE NEKROSIS, REPERFUSION DAMAGE, BACTERIAL TRANSLATION, AND ATOMIC SYNDROME IN ADULTS
GB2303064B (en) Medicament for nasal administration
AU2537997A (en) Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament
AU8933391A (en) Medical drug formulation and delivery system
DE69534887D1 (de) Gerät zur intrapulmonaren Arzneiverabreichung in therapeutisch relevanten Einatmungsfluss/Volumenwerten
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
PL297399A1 (en) Masked taste pharmaceutical preparations
AUPN973596A0 (en) Control of delivery pressure in cpap treatment or assisted respiration
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
AU6042696A (en) Drug delivery catheters and methods of use
TW410596U (en) Liquid-permeable topsheet for body exudates absorbent article and apparatus for manufacturing same
AU2537897A (en) Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament
EP1600168A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
AU5263496A (en) Targeted catheter drug administration
AU3127697A (en) Intravenous catheter and delivery system
EP1139746A4 (en) CONNECTIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISEASES AND THE ADMINISTRATION OF MEDICINAL SUBSTANCES
FI964332A0 (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
GB9103764D0 (en) Compositions
NO973292D0 (no) On-line medikamentleveringssystem i ekstrakorporeal terapi
AU7681091A (en) Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
AU2590697A (en) Anesthetizing plastics, drug delivery plastics, and related medical products, s ystems and methods